Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03564691
Brief Title: Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)

First Submitted : June 11, 2018
First Submitted that Met QC Criteria : June 11, 2018
First Posted : June 21, 2018

Last Update Submitted that Met QC Criteria : February 19, 2021
Last Update Posted : February 21, 2021